Aprikos Pharma LLP

Aprikos Pharma LLP - pharma in Delhi, India. Directors, charges & compliance details.
LLPIN AAG-6008 Incorporated 08 June 2016 ROC Delhi HQ Delhi, India
Active Limited Liability Partnership pharma
Data last updated
Contribution obligation
₹1 Lakh
As per LLP agreement
LLP age
10 yrs
Est. 2016
Designated partners
2
As per MCA filings
Active GSTINs
1
of 2 registered
Last financials
Mar 2025
Balance sheet date
LLP status
Active
MCA master data
Registrar
Delhi
ROC office
Incorporated
08 Jun 2016
Date of incorporation

About Aprikos Pharma LLP

Data last updated:

Aprikos Pharma LLP is a limited liability partnership (LLP) based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 June 2016 and has been in existence for over 10 years.

The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAG-6008. Its GSTIN is 07ABFFA4310B1Z8 (Delhi). The LLP holds 2 GST registrations, of which 1 is active.

The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Komal Arora and Umesh Arora.

Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at C – 15 Greater Kailash Enclave – 1 New Delhi, Delhi, India – 110048.

Company Details of Aprikos Pharma LLP
LLPIN AAG-6008
Incorporation Date 08 June 2016
Total Obligation of Contribution ₹1 Lakh
ROC Delhi
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025
Key People
Komal Arora Designated Partner Umesh Arora Designated Partner
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    C – 15 Greater Kailash Enclave – 1 New Delhi, Delhi, India – 110048
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Aprikos Pharma LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Aprikos Pharma LLP report

Financials, compliance, directors, charges, ownership and filings for Aprikos Pharma LLP in one report.

Financials from FY 2017 Directors & ownership Charges & compliance

Financials of Aprikos Pharma LLP FY 2025 filings available

Financial Statement Summary of Aprikos Pharma LLP

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Income and Expenditure
Turnover••••••••••••••••••••
Other Income••••••••••••••••••••
Total Income••••••••••••••••••••
Purchases and Direct Costs••••••••••••••••••••
Personnel Expenses••••••••••••••••••••
Administrative Expenses••••••••••••••••••••
Interest••••••••••••••••••••
Depreciation••••••••••••••••••••
Total Expenses••••••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax••••••••••••••••••••
Profit After Tax••••••••••••••••••••
Profit Transferred to Partners••••••••••••••••••••
Assets and Liabilities
Partners' Contribution••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Secured Loans••••••••••••••••••••
Unsecured Loans••••••••••••••••••••
Trade Payables••••••••••••••••••••
Other Liabilities and Provisions••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Loans and Advances••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Aprikos Pharma LLP

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
Net Profit Margin••••••••••••••••••••
Return on Partners' Funds••••••••••••••••••••
Return on Assets••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Debt to Partners' Funds••••••••••••••••••••
Interest Coverage••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Turnover Growth••••••••••••••••••••
Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Aprikos Pharma are in the company report.

Premium access

Financial statements from FY 2017

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Designated Partners of Aprikos Pharma LLP

Aprikos Pharma has 2 designated partners on record. No former designated partners are listed.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Komal Arora
Also directs: A and A Curewell LLP, Shubhnivesh Realcomm LLP, Ashtha Buildwell Private Limited and 2 more
Designated Partner08 Jun 201610 Years 3 MonthsCurrent
Umesh Arora
Also directs: A and A Curewell LLP, Shubhnivesh Realcomm LLP, Verve Infrabuild Private Limited and 5 more
Designated Partner08 Jun 201610 Years 3 MonthsCurrent
View all designated partners

Charges & Borrowings of Aprikos Pharma LLP

Aprikos Pharma LLP does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Aprikos Pharma LLP

Employment history and EPFO contributions of people linked to Aprikos Pharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Aprikos Pharma LLP

Aprikos Pharma LLP has 2 designated partner changes on record since 2016: 2 appointments. The latest: Komal Arora was appointed as Designated Partner on 08 Jun 2016.

AGM
Aprikos Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Aprikos Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Komal Arora was appointed as Designated Partner.
Appointed
Umesh Arora was appointed as Designated Partner.
Incorporation
08 Jun 2016
Aprikos Pharma Llp was registered on 08 Jun 2016 with Roc Delhi & aged 10 years 4 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Aprikos Pharma LLP

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Aprikos Pharma LLP

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Aprikos Pharma LLP

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Aprikos Pharma LLP

Aprikos Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
07ABFFA4310B1Z8DelhiActive05 May 2019
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Aprikos Pharma LLP

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aprikos Pharma LLP

Aprikos Pharma is an active limited liability partnership based in Delhi, India. The LLP works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 June 2016 (10+ years old) and is registered under LLPIN AAG-6008.

Aprikos Pharma has 2 current designated partners:

The GSTIN of Aprikos Pharma is 07ABFFA4310B1Z8, registered in Delhi. The LLP has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The LLPIN (Limited Liability Partnership Identification Number) of Aprikos Pharma is AAG-6008. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Aprikos Pharma was incorporated on 08 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.

Komal Arora was appointed as Designated Partner on 08 Jun 2016. Umesh Arora was appointed as Designated Partner on 08 Jun 2016.

The registered office of Aprikos Pharma is at C – 15 Greater Kailash Enclave – 1 New Delhi, Delhi, India – 110048.

The total obligation of contribution is ₹1 Lakh.

Aprikos Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

Aprikos Pharma can be reached at its registered office: C – 15 Greater Kailash Enclave – 1 New Delhi, Delhi, India – 110048.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available